Objective To study the expressions of prothrombin fragment 1 + 2 (F1 +2 ) and soluble fibrin monomer complex (SFMC) in the patients with heart-blood stasis syndrome of coronary heart disease (CHD). Methods The patients with heart-blood stasis syndrome of CHD (CHD group 1, n =26), patients with non-heart-blood stasis syndrome of CHD (CHD group 2, n = 30) and health people (health group, n = 28) were selected. The blood samples were collected on an empty stomach in the morning. The levels of F1 +2 and SFMC were detected by using EL...